nodes	percent_of_prediction	percent_of_DWPC	metapath
Metipranolol—Pindolol—HTR1B—schizophrenia	0.00709	0.118	CrCbGaD
Metipranolol—Alprenolol—HTR1A—schizophrenia	0.00652	0.108	CrCbGaD
Metipranolol—Pindolol—HTR1A—schizophrenia	0.00561	0.0932	CrCbGaD
Metipranolol—Acebutolol—CYP2D6—schizophrenia	0.00431	0.0716	CrCbGaD
Metipranolol—Oxprenolol—CYP2D6—schizophrenia	0.00428	0.0711	CrCbGaD
Metipranolol—Alprenolol—CYP2D6—schizophrenia	0.00391	0.065	CrCbGaD
Metipranolol—Propranolol—HTR1B—schizophrenia	0.00387	0.0643	CrCbGaD
Metipranolol—Metoprolol—CYP2D6—schizophrenia	0.00364	0.0604	CrCbGaD
Metipranolol—Pindolol—CYP2D6—schizophrenia	0.00337	0.0559	CrCbGaD
Metipranolol—Atenolol—ABCB1—schizophrenia	0.00334	0.0554	CrCbGaD
Metipranolol—Acebutolol—ABCB1—schizophrenia	0.00308	0.0511	CrCbGaD
Metipranolol—Propranolol—HTR1A—schizophrenia	0.00306	0.0509	CrCbGaD
Metipranolol—Metoprolol—ABCB1—schizophrenia	0.0026	0.0432	CrCbGaD
Metipranolol—Propranolol—CYP1A2—schizophrenia	0.00238	0.0395	CrCbGaD
Metipranolol—Propranolol—CYP2D6—schizophrenia	0.00184	0.0305	CrCbGaD
Metipranolol—Propranolol—ABCB1—schizophrenia	0.00131	0.0218	CrCbGaD
Metipranolol—ADRB2—GPCR ligand binding—OXT—schizophrenia	0.00119	0.00127	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—PPP3CC—schizophrenia	0.00119	0.00127	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—GRM2—schizophrenia	0.00119	0.00127	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—TAAR6—schizophrenia	0.00119	0.00127	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—NGEF—schizophrenia	0.00119	0.00126	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—NTS—schizophrenia	0.00118	0.00126	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—HTR1A—schizophrenia	0.00117	0.00125	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—PPP3CC—schizophrenia	0.00116	0.00124	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—GRM2—schizophrenia	0.00116	0.00124	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—TAAR6—schizophrenia	0.00116	0.00124	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—NTS—schizophrenia	0.00116	0.00123	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—NPS—schizophrenia	0.00115	0.00123	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—HTR1A—schizophrenia	0.00115	0.00122	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—DRD1—schizophrenia	0.00113	0.0012	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—HTR2C—schizophrenia	0.00113	0.0012	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—NPS—schizophrenia	0.00113	0.0012	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—RGS4—schizophrenia	0.00111	0.00119	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—GRM3—schizophrenia	0.00111	0.00119	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—DRD1—schizophrenia	0.00111	0.00118	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—HTR2C—schizophrenia	0.00111	0.00118	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—NGEF—schizophrenia	0.0011	0.00117	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—DRD3—schizophrenia	0.0011	0.00117	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—HTR6—schizophrenia	0.00109	0.00116	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—GRM3—schizophrenia	0.00109	0.00116	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—RGS4—schizophrenia	0.00109	0.00116	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—NGEF—schizophrenia	0.00108	0.00115	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—NTS—schizophrenia	0.00108	0.00114	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—DRD3—schizophrenia	0.00107	0.00114	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—HTR6—schizophrenia	0.00107	0.00114	CbGpPWpGaD
Metipranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—schizophrenia	0.00106	0.00113	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—DRD4—schizophrenia	0.00106	0.00113	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—NTS—schizophrenia	0.00105	0.00112	CbGpPWpGaD
Metipranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—schizophrenia	0.00104	0.00111	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—DRD4—schizophrenia	0.00104	0.00111	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—CNR1—schizophrenia	0.00102	0.00108	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—RGS4—schizophrenia	0.00101	0.00108	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—GRM3—schizophrenia	0.00101	0.00108	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—CNR1—schizophrenia	0.000994	0.00106	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—HTR6—schizophrenia	0.000993	0.00106	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—DRD2—schizophrenia	0.000992	0.00106	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—HTR7—schizophrenia	0.000992	0.00106	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—RGS4—schizophrenia	0.00099	0.00105	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—GRM3—schizophrenia	0.00099	0.00105	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—HTR6—schizophrenia	0.000971	0.00103	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—DRD2—schizophrenia	0.00097	0.00103	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—HTR7—schizophrenia	0.00097	0.00103	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—CHRM1—schizophrenia	0.000966	0.00103	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—CHRM1—schizophrenia	0.000945	0.00101	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—IL3RA—schizophrenia	0.000941	0.001	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—IL3RA—schizophrenia	0.000921	0.00098	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—schizophrenia	0.000912	0.00097	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—GRM5—schizophrenia	0.000898	0.000955	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—schizophrenia	0.000892	0.000949	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—DGKI—schizophrenia	0.000879	0.000935	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—GRM5—schizophrenia	0.000878	0.000935	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—CHRM1—schizophrenia	0.000877	0.000933	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—DGKI—schizophrenia	0.00086	0.000915	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—CHRM1—schizophrenia	0.000858	0.000913	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—IL3RA—schizophrenia	0.000855	0.000909	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—IL3RA—schizophrenia	0.000836	0.00089	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—CCK—schizophrenia	0.000821	0.000874	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—GRM5—schizophrenia	0.000815	0.000868	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PPP1R1B—schizophrenia	0.000804	0.000856	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—CCK—schizophrenia	0.000803	0.000855	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—PDE4B—schizophrenia	0.0008	0.000852	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—GRM5—schizophrenia	0.000798	0.000849	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—CCKAR—schizophrenia	0.000787	0.000838	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PPP1R1B—schizophrenia	0.000787	0.000837	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—PDE4B—schizophrenia	0.000783	0.000833	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—CCKAR—schizophrenia	0.00077	0.00082	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—ADORA2A—schizophrenia	0.000763	0.000812	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—FZD3—schizophrenia	0.000748	0.000795	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—ADORA2A—schizophrenia	0.000747	0.000795	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—CCK—schizophrenia	0.000746	0.000794	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—FZD3—schizophrenia	0.000731	0.000778	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—CCK—schizophrenia	0.00073	0.000776	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—PDE4B—schizophrenia	0.000727	0.000773	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—CCKAR—schizophrenia	0.000715	0.000761	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—NPY—schizophrenia	0.000713	0.000759	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—PDE4B—schizophrenia	0.000711	0.000756	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PPP3CC—schizophrenia	0.000703	0.000748	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—TAAR6—schizophrenia	0.000703	0.000748	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GRM2—schizophrenia	0.000703	0.000748	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—FES—schizophrenia	0.000703	0.000748	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—CCKAR—schizophrenia	0.000699	0.000744	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—NPY—schizophrenia	0.000698	0.000742	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—HTR2A—schizophrenia	0.000695	0.000739	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—ADORA2A—schizophrenia	0.000693	0.000738	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—HTR1B—schizophrenia	0.000688	0.000732	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—OXT—schizophrenia	0.000688	0.000732	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PPP3CC—schizophrenia	0.000687	0.000732	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—FES—schizophrenia	0.000687	0.000732	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—TAAR6—schizophrenia	0.000687	0.000732	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GRM2—schizophrenia	0.000687	0.000732	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—HTR2A—schizophrenia	0.000679	0.000723	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—ADORA2A—schizophrenia	0.000678	0.000722	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—HTR1B—schizophrenia	0.000673	0.000716	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—OXT—schizophrenia	0.000673	0.000716	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—HTR1A—schizophrenia	0.000662	0.000705	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—NPS—schizophrenia	0.000652	0.000694	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NGEF—schizophrenia	0.00065	0.000692	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—HTR1A—schizophrenia	0.000648	0.00069	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—NPY—schizophrenia	0.000648	0.000689	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—DRD1—schizophrenia	0.00064	0.000681	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—HTR2C—schizophrenia	0.00064	0.000681	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—NPS—schizophrenia	0.000638	0.000679	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NGEF—schizophrenia	0.000636	0.000677	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NTS—schizophrenia	0.000636	0.000676	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—NPY—schizophrenia	0.000634	0.000674	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—DRD1—schizophrenia	0.000626	0.000666	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—HTR2C—schizophrenia	0.000626	0.000666	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—HTR1B—schizophrenia	0.000625	0.000665	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—OXT—schizophrenia	0.000625	0.000665	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NTS—schizophrenia	0.000622	0.000662	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—DRD3—schizophrenia	0.00062	0.000659	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—OXT—schizophrenia	0.000611	0.000651	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—HTR1B—schizophrenia	0.000611	0.000651	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—DRD3—schizophrenia	0.000606	0.000645	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—HTR1A—schizophrenia	0.000602	0.00064	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—DRD4—schizophrenia	0.000602	0.00064	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—RGS4—schizophrenia	0.000598	0.000636	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—RTN4—schizophrenia	0.000598	0.000636	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GRM3—schizophrenia	0.000598	0.000636	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—NPS—schizophrenia	0.000592	0.00063	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—HTR1A—schizophrenia	0.000588	0.000626	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—DRD4—schizophrenia	0.000588	0.000626	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HTR6—schizophrenia	0.000587	0.000624	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GRM3—schizophrenia	0.000585	0.000622	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—RGS4—schizophrenia	0.000585	0.000622	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—RTN4—schizophrenia	0.000585	0.000622	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—HTR2C—schizophrenia	0.000581	0.000618	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—DRD1—schizophrenia	0.000581	0.000618	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—NPS—schizophrenia	0.00058	0.000617	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—CNR1—schizophrenia	0.000574	0.000611	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HTR6—schizophrenia	0.000574	0.000611	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—HTR2C—schizophrenia	0.000568	0.000605	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—DRD1—schizophrenia	0.000568	0.000605	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—MAG—schizophrenia	0.000567	0.000603	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—DRD3—schizophrenia	0.000563	0.000599	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—CNR1—schizophrenia	0.000562	0.000598	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—DRD2—schizophrenia	0.00056	0.000596	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—HTR7—schizophrenia	0.00056	0.000596	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—MAG—schizophrenia	0.000554	0.00059	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—DRD3—schizophrenia	0.00055	0.000586	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—HTR7—schizophrenia	0.000548	0.000583	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—DRD2—schizophrenia	0.000548	0.000583	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—DRD4—schizophrenia	0.000546	0.000581	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—DRD4—schizophrenia	0.000534	0.000569	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—CNR1—schizophrenia	0.000522	0.000555	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CHRM1—schizophrenia	0.000518	0.000551	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—CNR1—schizophrenia	0.00051	0.000543	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—DRD2—schizophrenia	0.000509	0.000541	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—HTR7—schizophrenia	0.000509	0.000541	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CHRM1—schizophrenia	0.000507	0.000539	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—IL3RA—schizophrenia	0.000505	0.000537	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—HTR7—schizophrenia	0.000498	0.00053	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—DRD2—schizophrenia	0.000498	0.00053	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—IL3RA—schizophrenia	0.000494	0.000526	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—TLE1—schizophrenia	0.000493	0.000524	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NRG3—schizophrenia	0.000493	0.000524	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GFAP—schizophrenia	0.000487	0.000518	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—TLE1—schizophrenia	0.000482	0.000513	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NRG3—schizophrenia	0.000482	0.000513	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GRM5—schizophrenia	0.000482	0.000513	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GFAP—schizophrenia	0.000477	0.000507	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GRM5—schizophrenia	0.000471	0.000501	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—TLE3—schizophrenia	0.000467	0.000496	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—TLE3—schizophrenia	0.000456	0.000486	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CCK—schizophrenia	0.000441	0.000469	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CCK—schizophrenia	0.000431	0.000459	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PDE4B—schizophrenia	0.000429	0.000457	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CCKAR—schizophrenia	0.000422	0.000449	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PDE4B—schizophrenia	0.00042	0.000447	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CCKAR—schizophrenia	0.000413	0.00044	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—ADORA2A—schizophrenia	0.00041	0.000436	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—PLA2G4A—schizophrenia	0.000403	0.000429	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—ADORA2A—schizophrenia	0.000401	0.000426	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—PLA2G4A—schizophrenia	0.000394	0.000419	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—FGA—schizophrenia	0.000393	0.000418	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—HTR2A—schizophrenia	0.000392	0.000418	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—FGA—schizophrenia	0.000384	0.000409	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—HTR2A—schizophrenia	0.000384	0.000409	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NPY—schizophrenia	0.000383	0.000407	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NOTCH4—schizophrenia	0.000383	0.000407	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—ATP2A2—schizophrenia	0.000383	0.000407	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NPY—schizophrenia	0.000374	0.000398	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NOTCH4—schizophrenia	0.000374	0.000398	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—ATP2A2—schizophrenia	0.000374	0.000398	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—OXT—schizophrenia	0.000369	0.000393	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HTR1B—schizophrenia	0.000369	0.000393	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HTR1B—schizophrenia	0.000361	0.000384	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—OXT—schizophrenia	0.000361	0.000384	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—HTR2A—schizophrenia	0.000356	0.000379	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HTR1A—schizophrenia	0.000355	0.000378	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NPS—schizophrenia	0.00035	0.000372	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—HTR2A—schizophrenia	0.000349	0.000371	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HTR1A—schizophrenia	0.000348	0.00037	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HTR2C—schizophrenia	0.000343	0.000365	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—DRD1—schizophrenia	0.000343	0.000365	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NPS—schizophrenia	0.000342	0.000364	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HTR2C—schizophrenia	0.000336	0.000357	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—DRD1—schizophrenia	0.000336	0.000357	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NTRK2—schizophrenia	0.000334	0.000355	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—DRD3—schizophrenia	0.000332	0.000354	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NTRK2—schizophrenia	0.000327	0.000348	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—DRD3—schizophrenia	0.000325	0.000346	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—DRD4—schizophrenia	0.000323	0.000343	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—DRD4—schizophrenia	0.000316	0.000336	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CNR1—schizophrenia	0.000308	0.000328	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CNR1—schizophrenia	0.000301	0.000321	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—DRD2—schizophrenia	0.000301	0.00032	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HTR7—schizophrenia	0.000301	0.00032	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HTR7—schizophrenia	0.000294	0.000313	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—DRD2—schizophrenia	0.000294	0.000313	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PRL—schizophrenia	0.000284	0.000302	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PRL—schizophrenia	0.000278	0.000295	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—S100B—schizophrenia	0.000265	0.000282	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—S100B—schizophrenia	0.000259	0.000275	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—ERBB4—schizophrenia	0.000253	0.000269	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—ERBB4—schizophrenia	0.000248	0.000263	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PLA2G4A—schizophrenia	0.000238	0.000253	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NRG1—schizophrenia	0.000234	0.000248	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PLA2G4A—schizophrenia	0.000233	0.000248	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—MEF2C—schizophrenia	0.000231	0.000246	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NRG1—schizophrenia	0.000228	0.000243	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—MEF2C—schizophrenia	0.000226	0.000241	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—YWHAZ—schizophrenia	0.000224	0.000238	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—YWHAZ—schizophrenia	0.000219	0.000233	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—ERBB3—schizophrenia	0.000219	0.000233	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—ERBB3—schizophrenia	0.000214	0.000228	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HTR2A—schizophrenia	0.000211	0.000224	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HTR2A—schizophrenia	0.000206	0.000219	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—APOE—schizophrenia	0.000196	0.000208	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—APOA1—schizophrenia	0.000193	0.000206	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—APOE—schizophrenia	0.000191	0.000204	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—APOA1—schizophrenia	0.000189	0.000201	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—ESR1—schizophrenia	0.000187	0.000199	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—ESR1—schizophrenia	0.000183	0.000195	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GSK3B—schizophrenia	0.00017	0.00018	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GSK3B—schizophrenia	0.000166	0.000176	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—AKT1—schizophrenia	0.000126	0.000134	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—AKT1—schizophrenia	0.000123	0.000131	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—AKT1—schizophrenia	0.000114	0.000121	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—AKT1—schizophrenia	0.000112	0.000119	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—EP300—schizophrenia	0.000112	0.000119	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—EP300—schizophrenia	0.000109	0.000116	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—TP53—schizophrenia	7.98e-05	8.49e-05	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—TP53—schizophrenia	7.81e-05	8.31e-05	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—AKT1—schizophrenia	6.74e-05	7.17e-05	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—AKT1—schizophrenia	6.59e-05	7.02e-05	CbGpPWpGaD
